Work

Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell Carcinoma

Year: 2018

Type: article

Study design: Clinical Trial

Source: Clinical Genitourinary Cancer

DOI: 10.1016/j.clgc.2018.04.001

Authors: Xin Gao, Opeyemi Jegede, Connor Gray, Paul J. Catalano, Jesse Novak, David J. Kwiatkowski, Rana R. McKay, Daniel J. George, Toni K. Choueiri, David F. McDermott, Sabina Signoretti, Rupal S. Bhatt

Institutions: Beth Israel Deaconess Medical Center, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Brigham and Women's Hospital, Duke University, Duke Medical Center, Duke Cancer Institute

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Center for Advancing Translational Sciences

Awards: G1273380608, G1470284823, G8667473375, G988903100

OpenAlex ID: W2802855637

FWCI: 0.676

Cites: 21

Cited by: 8

Related to: 10